Scientific Advisory Board
Get to know our board and its world-renowned members!
Our Axplora Scientific Advisory Board (SAB) brings together leading international experts with complementary areas of expertise, spanning from catalysis, electrochemistry, steroids to biochemistry and ADCs.
Mission, role & responsibilities
This advisory body plays a key role in following market trends & shaping our R&D activities and focus on supporting the deployment of innovative technologies and modalities at Axplora. The Board’s insight and guidance, associated with our expertise, are harnessed to meet the challenges of API development & manufacturing for the benefit of our clients and their patients.
The members of our SAB help us to increase Axplora’s visibility and to be recognized as an important player in specific technologies.
They are committed to:
- Attending regular SAB meetings every year with the aim to:
- Assess Axplora’s innovation projects and directions,
- Propose to Axplora potential innovation projects, directions, and partners.
- Participating in seminars and/or customer visits with Axplora’s representatives, in Europe or overseas, and presenting scientific lectures of research conducted by our team to position Axplora as an innovative and scientific leader.
- Assisting Axplora in scientifically related tasks, such as literature surveys, helping R&D personnel to solve scientific or technical issues, etc.
Dr. David Cantillo is a group leader and senior lecturer at the University of Queensland. He is an eminent researcher with particular expertise in flow chemistry, electrochemistry and photochemistry.
Prof. Alois Fürstner is currently Director at the Max-Planck-Institute für Kohlenforschung, Mülheim/Ruhr, Germany, an elite institution in the area of catalysis research for more than a century.
He is renowned for his expertise in the field of homogeneous catalysis, organometallic chemistry, and target-oriented synthesis. In recognition of his work, he received numerous awards.
Professor Fürstner has been Editor-in-Chief of “Science of Synthesis” since 2017.
Prof. Kerry Chester is Professor of Molecular Medicine at UCL, a top global university, and she is on the Board of Directors of The Antibody Society. Kerry’s group created and manufactured the first single chain Fv antibody (scFv) to enter clinical trials and she has over 30 years’ experience in development of antibody-based therapeutics.
Prof. John Woodley is Professor of Chemical Engineering in the Department of Chemical and Biochemical Engineering at Technical University of Denmark.
Expert in biochemical engineering and biocatalysis, he collaborated with many universities (Dortmund, GE; Graz, AT; Manchester, UK; or North Carolina State University, USA) and industrial players such as Sigma-Aldrich, Novozymes, BASF and Lonza. He received several awards and honors throughout his successful career.
Dr. Michael Reschke is Director / Consultant at Reschke Technology Consulting. He has more than 30 years’ experience in steroids and bile acids and has expertise in large-scale fermentation of steroid intermediates.